diethylenetriaminepentaacetic acid; GSA-RL, GSA-Rmax of the estimated residual liver; GSA-Rmax, maximal removal rate of 99m Tc -GSA; SPECT, single-photon emission computed tomography; 99m Tc-GSA, 99m Tc-galactosyl human serum albumin; VOI, volume of interest
Key results:The median GSA-RL was 0.393 [range, 0.057-0.729] mg/min, GSA-Rmax after CIRT was 0.369 [range, 0.037-0.780] mg/min (P = .40).The linear regression equation representing the relationship between the GSA-RL and GSA-Rmax after CIRT was y = 0.05 + 0.84x (R 2 = 0.67, P < .0001). There was a positive correlation between the estimated and actual post-treatment values as well as in the group with impaired liver reserve (R 2 = 0.62, P = .0005).A summary statement: 99m Tc-GSA scintigraphy can be used to accurately estimate liver reserve capacity after carbon-ion radiotherapy in patients with liver tumors regardless of disease severity.Results: Overall, 50 patients were included (mean age ± standard deviation, 73 years ± 11; range, 29-89 years, 35 men). The median GSA-RL was 0.393 [range, 0.057-0.729] mg/min, the median GSA-Rmax after CIRT was 0.369 [range, 0.037-0.780] mg/min (P = .40). The linear regression equation representing the relationship between the GSA-RL and GSA-Rmax after CIRT was y = 0.05 + 0.84x (R 2 = 0.67, P < .0001). There was a positive correlation between the estimated and actual post-treatment values for all patients, as well as in the group with impaired liver reserve capacity (y = -0.02 + 1.09x (R 2 = 0.62, P = .0005)).Conclusions: 99m Tc-GSA scintigraphy has potential clinical utility for estimating the residual liver reserve capacity in patients undergoing carbon-ion radiotherapy for liver tumors. Clinical Trial registration: UMIN000038328, https://center6.umin.ac.jp/cgi-openbin/ctr/ctr_view.cgi?recptno=R000043545